Date

Wednesday, 05 December 2012

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Minutes of the COMP meeting 5-6 December 2012

Agenda - COMP agenda of the 5-6 December 2012 meeting

How useful do you find this page?